Corvus Pharma Com (CRVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CRVS | AZN | AMGN | GILD | BMY |
| Company | Corvus Pharma Com | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 15.41 | 183.93 | 335.01 | 128.90 | 57.65 |
| High | 15.55 | 187.00 | 339.12 | 129.96 | 58.38 |
| Low | 14.11 | 181.73 | 333.55 | 128.00 | 57.28 |
| Latest | 14.42 | 185.20 | 338.02 | 128.84 | 57.59 |
| Change | -1.20 | -1.48 | -1.55 | -0.42 | -0.67 |
| % Change | -7.68% | -0.79% | -0.46% | -0.32% | -1.15% |
| Volume | 2,051,200 | 4,443,000 | 2,516,500 | 5,048,200 | 9,462,700 |
| 20-Day Average Volume | 1,241,465 | 2,018,020 | 2,402,840 | 5,245,205 | 8,918,090 |
| Previous Close | 15.62 | 186.68 | 339.57 | 129.26 | 58.26 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 15.49 | 198.35 | 347.29 | 136.45 | 58.87 |
| 20-Day Raw Stochastic | 8.65% | 13.57% | 17.26% | 7.83% | 7.39% |
| 20-Day Relative Strength | 45.46 | 39.06 | 40.54 | 35.66 | 45.50 |
| Weighted Alpha | +11.91 | +24.04 | +17.59 | +18.69 | +17.91 |
| Today's Opinion | 48% Buy | 40% Buy | 8% Buy | 8% Buy | 40% Buy |
| Previous Opinion | 72% Buy | 40% Buy | 8% Buy | 8% Buy | 40% Buy |
| Last Month's Opinion | 40% Buy | 72% Buy | 40% Buy | 40% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -19.22% since 04/22/26 | -4.93% since 04/22/26 | -2.28% since 04/22/26 | -3.05% since 04/22/26 | -2.06% since 04/22/26 |
| Low | 14.11 on 04/29/26 | 181.73 on 04/29/26 | 333.55 on 04/29/26 | 127.64 on 04/27/26 | 57.28 on 04/29/26 |
| High | 17.89 on 04/23/26 | 196.64 on 04/23/26 | 350.69 on 04/23/26 | 134.68 on 04/23/26 | 59.25 on 04/23/26 |
| 1-Month | |||||
| %Chg | +2.93% since 03/27/26 | -1.71% since 03/27/26 | -3.08% since 03/27/26 | -4.03% since 03/27/26 | -1.62% since 03/27/26 |
| Low | 13.16 on 03/30/26 | 181.73 on 04/29/26 | 333.55 on 04/29/26 | 127.64 on 04/27/26 | 57.22 on 04/15/26 |
| High | 19.70 on 04/22/26 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 62.22 on 04/01/26 |
| 3-Month | |||||
| %Chg | -31.14% since 01/29/26 | +0.01% since 01/29/26 | -1.43% since 01/29/26 | -7.67% since 01/29/26 | +6.10% since 01/29/26 |
| Low | 12.95 on 03/20/26 | 181.73 on 04/29/26 | 333.55 on 04/29/26 | 127.64 on 04/27/26 | 54.33 on 01/30/26 |
| High | 22.34 on 02/02/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +87.76% since 10/29/25 | +12.61% since 10/29/25 | +15.85% since 10/29/25 | +8.73% since 10/29/25 | +35.19% since 10/29/25 |
| Low | 6.39 on 01/12/26 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 43.19 on 10/30/25 |
| High | 26.95 on 01/23/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,313,486 | 289,523,488 | 183,260,832 | 160,440,352 | 118,951,480 |
| Shares Outstanding, K | 84,090 | 1,550,908 | 539,685 | 1,241,222 | 2,041,735 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -15,280,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -12,320,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 0.97 | 0.35 | 0.47 | 0.39 | 0.27 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.15 on 03/12/26 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Earnings Date | 05/14/26 | 04/29/26 | 04/30/26 | 05/07/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.47 | 15.57 | 15.67 | 9.40 |